|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6750 GBX | 0.00% |
|
0.00% | +28.57% |
| Market Cap | 56.18L 75.58L 65.59L 61.41L 1.06Cr 72Cr 1.07Cr 7.18Cr 2.82Cr 36Cr 2.84Cr 2.78Cr 119.73Cr | P/E 2024 |
-1.69x | P/E 2025 | -3.09x |
|---|---|---|---|---|---|
| Enterprise Value | 45.39L 61.06L 52.99L 49.62L 85.68L 58Cr 86.8L 5.8Cr 2.28Cr 29Cr 2.29Cr 2.24Cr 97Cr | EV / Sales 2024 |
19,86,57,512x | EV / Sales 2025 | 45,29,41,079x |
| Free-Float |
41.35% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Thalia Therapeutics Plc
| 1 month | +3.85% | ||
| 3 months | +17.39% | ||
| 6 months | +42.11% | ||
| Current year | +28.57% |
| 1 week | 0.65 |  | 0.7 |
| 1 month | 0.6 | | 0.75 |
| Current year | 0.4 | | 0.95 |
| 1 year | 0.4 | | 1 |
| 3 years | 0.35 | | 1.7 |
| 5 years | 0.35 | | 10.12 |
| 10 years | 0.35 | | 35.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Solomon
CEO | Chief Executive Officer | 66 | 24/02/2026 |
Rachel Schiller
COO | Chief Operating Officer | - | - |
Fiona McLaughlin
CTO | Chief Tech/Sci/R&D Officer | 56 | 27/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Cairns
BRD | Director/Board Member | 48 | 14/07/2020 |
| Chairman | 59 | 01/08/2023 | |
| Director/Board Member | 81 | 09/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/11/24 | Free | Founder | 60,00,000 | 1.5198% | ||
| 28/11/24 | Free | Director | 30,00,000 | 0.7599% | ||
| 28/11/24 | Free | Chairman | 30,00,000 | 0.7599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +50.00% | -57.81% | 75.58L | |
| -3.25% | +13.72% | +52.49% | +88.86% | 6.29TCr | |
| +3.00% | +4.21% | +34.84% | +75.62% | 5.43TCr | |
| -1.07% | -1.79% | -18.07% | -14.36% | 2.29TCr | |
| +33.86% | +30.60% | +19.14% | +502.77% | 2.87TCr | |
| +10.83% | +18.38% | +52.76% | +4.58% | 2.16TCr | |
| +9.43% | +10.36% | +41.79% | -19.28% | 1.78TCr | |
| -3.37% | +25.85% | +213.21% | +369.13% | 1.65TCr | |
| +6.20% | +11.51% | +34.94% | +681.88% | 1.55TCr | |
| -7.94% | -6.74% | +38.42% | +157.52% | 1.31TCr | |
| Average | +4.78% | +7.27% | +51.95% | +178.89% | 2.53TCr | |
| Weighted average by Cap. | +4.92% | +8.61% | +46.47% | +166.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.01 0.01 0.01 0.01 0.01 0.93 0.01 0.09 0.04 0.47 0.04 0.04 1.55 | 0.01 0.01 0.01 0.01 0.01 0.93 0.01 0.09 0.04 0.47 0.04 0.04 1.55 |
| Net income | -10.59L -14.24L -12.36L -11.57L -19.99L -14Cr -20.25L -1.35Cr -53.13L -6.78Cr -53.47L -52.31L -23Cr | -12.05L -16.21L -14.07L -13.17L -22.75L -15Cr -23.05L -1.54Cr -60.48L -7.72Cr -60.87L -59.54L -26Cr |
| Net Debt | -6L -8L -7L -7L -11.82L -8.02Cr -11.97L -80.06L -31.42L -4.01Cr -31.62L -30.93L -13Cr | -10.79L -14.52L -12.6L -11.8L -20.38L -14Cr -20.64L -1.38Cr -54.17L -6.91Cr -54.52L -53.33L -23Cr |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | GBX 0.6750 | 0.00% | 1,89,301 |
| 06/26/06 | GBX 0.6750 | 0.00% | 81,802 |
| 05/26/05 | GBX 0.6750 | 0.00% | 74,667 |
| 04/26/04 | GBX 0.6750 | 0.00% | 2,02,941 |
| 03/26/03 | GBX 0.6750 | 0.00% | 2,38,579 |
- Stock Market
- Stocks
- THAT Stock
Select your edition
All financial news and data tailored to specific country editions
